Global Radioactive Therapeutic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Radioactive Therapeutic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
The Global Info Research report includes an overview of the development of the Radioactive Therapeutic Drugs industry chain, the market status of Hospitals (Oncology, Cardiology), Academic & Research Institutes (Oncology, Cardiology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioactive Therapeutic Drugs.
Regionally, the report analyzes the Radioactive Therapeutic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioactive Therapeutic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radioactive Therapeutic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioactive Therapeutic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, Cardiology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioactive Therapeutic Drugs market.
Regional Analysis: The report involves examining the Radioactive Therapeutic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioactive Therapeutic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radioactive Therapeutic Drugs:
Company Analysis: Report covers individual Radioactive Therapeutic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioactive Therapeutic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Radioactive Therapeutic Drugs. It assesses the current state, advancements, and potential future developments in Radioactive Therapeutic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioactive Therapeutic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radioactive Therapeutic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Radioactive Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Therapeutic Drugs, with revenue, gross margin and global market share of Radioactive Therapeutic Drugs from 2018 to 2023.
Chapter 3, the Radioactive Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Radioactive Therapeutic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Therapeutic Drugs.
Chapter 13, to describe Radioactive Therapeutic Drugs research findings and conclusion.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
The Global Info Research report includes an overview of the development of the Radioactive Therapeutic Drugs industry chain, the market status of Hospitals (Oncology, Cardiology), Academic & Research Institutes (Oncology, Cardiology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioactive Therapeutic Drugs.
Regionally, the report analyzes the Radioactive Therapeutic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioactive Therapeutic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radioactive Therapeutic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioactive Therapeutic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology, Cardiology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioactive Therapeutic Drugs market.
Regional Analysis: The report involves examining the Radioactive Therapeutic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioactive Therapeutic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radioactive Therapeutic Drugs:
Company Analysis: Report covers individual Radioactive Therapeutic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioactive Therapeutic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Radioactive Therapeutic Drugs. It assesses the current state, advancements, and potential future developments in Radioactive Therapeutic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioactive Therapeutic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radioactive Therapeutic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oncology
- Cardiology
- Others
- Hospitals
- Academic & Research Institutes
- Others
- Nihon Medi-Physics
- ITM Isotopen Technologien Mьnchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- GE Healthcare
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Lantheus Holdings, Inc.
- Curium Pharma
- Bayer AG
- Clarity Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Radioactive Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Therapeutic Drugs, with revenue, gross margin and global market share of Radioactive Therapeutic Drugs from 2018 to 2023.
Chapter 3, the Radioactive Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Radioactive Therapeutic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Therapeutic Drugs.
Chapter 13, to describe Radioactive Therapeutic Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Radioactive Therapeutic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioactive Therapeutic Drugs by Type
1.3.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Type in 2022
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Others
1.4 Global Radioactive Therapeutic Drugs Market by Application
1.4.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Academic & Research Institutes
1.4.4 Others
1.5 Global Radioactive Therapeutic Drugs Market Size & Forecast
1.6 Global Radioactive Therapeutic Drugs Market Size and Forecast by Region
1.6.1 Global Radioactive Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Radioactive Therapeutic Drugs Market Size by Region, (2018-2029)
1.6.3 North America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Nihon Medi-Physics
2.1.1 Nihon Medi-Physics Details
2.1.2 Nihon Medi-Physics Major Business
2.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Solutions
2.1.4 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nihon Medi-Physics Recent Developments and Future Plans
2.2 ITM Isotopen Technologien Mьnchen AG
2.2.1 ITM Isotopen Technologien Mьnchen AG Details
2.2.2 ITM Isotopen Technologien Mьnchen AG Major Business
2.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Solutions
2.2.4 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ITM Isotopen Technologien Mьnchen AG Recent Developments and Future Plans
2.3 Advanced Accelerator Applications
2.3.1 Advanced Accelerator Applications Details
2.3.2 Advanced Accelerator Applications Major Business
2.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Solutions
2.3.4 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Advanced Accelerator Applications Recent Developments and Future Plans
2.4 Telix Pharmaceuticals
2.4.1 Telix Pharmaceuticals Details
2.4.2 Telix Pharmaceuticals Major Business
2.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
2.4.4 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Telix Pharmaceuticals Recent Developments and Future Plans
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Radioactive Therapeutic Drugs Product and Solutions
2.5.4 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GE Healthcare Recent Developments and Future Plans
2.6 Theragnostics Ltd.
2.6.1 Theragnostics Ltd. Details
2.6.2 Theragnostics Ltd. Major Business
2.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Solutions
2.6.4 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Theragnostics Ltd. Recent Developments and Future Plans
2.7 NuView Life Sciences
2.7.1 NuView Life Sciences Details
2.7.2 NuView Life Sciences Major Business
2.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Product and Solutions
2.7.4 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NuView Life Sciences Recent Developments and Future Plans
2.8 Jubilant Pharma Limited
2.8.1 Jubilant Pharma Limited Details
2.8.2 Jubilant Pharma Limited Major Business
2.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Solutions
2.8.4 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jubilant Pharma Limited Recent Developments and Future Plans
2.9 Lantheus Holdings, Inc.
2.9.1 Lantheus Holdings, Inc. Details
2.9.2 Lantheus Holdings, Inc. Major Business
2.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Solutions
2.9.4 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lantheus Holdings, Inc. Recent Developments and Future Plans
2.10 Curium Pharma
2.10.1 Curium Pharma Details
2.10.2 Curium Pharma Major Business
2.10.3 Curium Pharma Radioactive Therapeutic Drugs Product and Solutions
2.10.4 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Curium Pharma Recent Developments and Future Plans
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Radioactive Therapeutic Drugs Product and Solutions
2.11.4 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bayer AG Recent Developments and Future Plans
2.12 Clarity Pharmaceuticals
2.12.1 Clarity Pharmaceuticals Details
2.12.2 Clarity Pharmaceuticals Major Business
2.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
2.12.4 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Clarity Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioactive Therapeutic Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Radioactive Therapeutic Drugs by Company Revenue
3.2.2 Top 3 Radioactive Therapeutic Drugs Players Market Share in 2022
3.2.3 Top 6 Radioactive Therapeutic Drugs Players Market Share in 2022
3.3 Radioactive Therapeutic Drugs Market: Overall Company Footprint Analysis
3.3.1 Radioactive Therapeutic Drugs Market: Region Footprint
3.3.2 Radioactive Therapeutic Drugs Market: Company Product Type Footprint
3.3.3 Radioactive Therapeutic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioactive Therapeutic Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Radioactive Therapeutic Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Radioactive Therapeutic Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
6.2 North America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
6.3 North America Radioactive Therapeutic Drugs Market Size by Country
6.3.1 North America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
7.2 Europe Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
7.3 Europe Radioactive Therapeutic Drugs Market Size by Country
7.3.1 Europe Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.3 France Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2018-2029)
8.3.2 China Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.5 India Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
9.2 South America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
9.3 South America Radioactive Therapeutic Drugs Market Size by Country
9.3.1 South America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Radioactive Therapeutic Drugs Market Drivers
11.2 Radioactive Therapeutic Drugs Market Restraints
11.3 Radioactive Therapeutic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioactive Therapeutic Drugs Industry Chain
12.2 Radioactive Therapeutic Drugs Upstream Analysis
12.3 Radioactive Therapeutic Drugs Midstream Analysis
12.4 Radioactive Therapeutic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Radioactive Therapeutic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioactive Therapeutic Drugs by Type
1.3.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Type in 2022
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Others
1.4 Global Radioactive Therapeutic Drugs Market by Application
1.4.1 Overview: Global Radioactive Therapeutic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Academic & Research Institutes
1.4.4 Others
1.5 Global Radioactive Therapeutic Drugs Market Size & Forecast
1.6 Global Radioactive Therapeutic Drugs Market Size and Forecast by Region
1.6.1 Global Radioactive Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Radioactive Therapeutic Drugs Market Size by Region, (2018-2029)
1.6.3 North America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Radioactive Therapeutic Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Nihon Medi-Physics
2.1.1 Nihon Medi-Physics Details
2.1.2 Nihon Medi-Physics Major Business
2.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Solutions
2.1.4 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nihon Medi-Physics Recent Developments and Future Plans
2.2 ITM Isotopen Technologien Mьnchen AG
2.2.1 ITM Isotopen Technologien Mьnchen AG Details
2.2.2 ITM Isotopen Technologien Mьnchen AG Major Business
2.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Solutions
2.2.4 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ITM Isotopen Technologien Mьnchen AG Recent Developments and Future Plans
2.3 Advanced Accelerator Applications
2.3.1 Advanced Accelerator Applications Details
2.3.2 Advanced Accelerator Applications Major Business
2.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Solutions
2.3.4 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Advanced Accelerator Applications Recent Developments and Future Plans
2.4 Telix Pharmaceuticals
2.4.1 Telix Pharmaceuticals Details
2.4.2 Telix Pharmaceuticals Major Business
2.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
2.4.4 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Telix Pharmaceuticals Recent Developments and Future Plans
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Radioactive Therapeutic Drugs Product and Solutions
2.5.4 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GE Healthcare Recent Developments and Future Plans
2.6 Theragnostics Ltd.
2.6.1 Theragnostics Ltd. Details
2.6.2 Theragnostics Ltd. Major Business
2.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Solutions
2.6.4 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Theragnostics Ltd. Recent Developments and Future Plans
2.7 NuView Life Sciences
2.7.1 NuView Life Sciences Details
2.7.2 NuView Life Sciences Major Business
2.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Product and Solutions
2.7.4 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NuView Life Sciences Recent Developments and Future Plans
2.8 Jubilant Pharma Limited
2.8.1 Jubilant Pharma Limited Details
2.8.2 Jubilant Pharma Limited Major Business
2.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Solutions
2.8.4 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jubilant Pharma Limited Recent Developments and Future Plans
2.9 Lantheus Holdings, Inc.
2.9.1 Lantheus Holdings, Inc. Details
2.9.2 Lantheus Holdings, Inc. Major Business
2.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Solutions
2.9.4 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lantheus Holdings, Inc. Recent Developments and Future Plans
2.10 Curium Pharma
2.10.1 Curium Pharma Details
2.10.2 Curium Pharma Major Business
2.10.3 Curium Pharma Radioactive Therapeutic Drugs Product and Solutions
2.10.4 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Curium Pharma Recent Developments and Future Plans
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Radioactive Therapeutic Drugs Product and Solutions
2.11.4 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bayer AG Recent Developments and Future Plans
2.12 Clarity Pharmaceuticals
2.12.1 Clarity Pharmaceuticals Details
2.12.2 Clarity Pharmaceuticals Major Business
2.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
2.12.4 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Clarity Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioactive Therapeutic Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Radioactive Therapeutic Drugs by Company Revenue
3.2.2 Top 3 Radioactive Therapeutic Drugs Players Market Share in 2022
3.2.3 Top 6 Radioactive Therapeutic Drugs Players Market Share in 2022
3.3 Radioactive Therapeutic Drugs Market: Overall Company Footprint Analysis
3.3.1 Radioactive Therapeutic Drugs Market: Region Footprint
3.3.2 Radioactive Therapeutic Drugs Market: Company Product Type Footprint
3.3.3 Radioactive Therapeutic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioactive Therapeutic Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Radioactive Therapeutic Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Radioactive Therapeutic Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
6.2 North America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
6.3 North America Radioactive Therapeutic Drugs Market Size by Country
6.3.1 North America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
7.2 Europe Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
7.3 Europe Radioactive Therapeutic Drugs Market Size by Country
7.3.1 Europe Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.3 France Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Radioactive Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2018-2029)
8.3.2 China Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.5 India Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
9.2 South America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
9.3 South America Radioactive Therapeutic Drugs Market Size by Country
9.3.1 South America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Radioactive Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Radioactive Therapeutic Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Radioactive Therapeutic Drugs Market Drivers
11.2 Radioactive Therapeutic Drugs Market Restraints
11.3 Radioactive Therapeutic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioactive Therapeutic Drugs Industry Chain
12.2 Radioactive Therapeutic Drugs Upstream Analysis
12.3 Radioactive Therapeutic Drugs Midstream Analysis
12.4 Radioactive Therapeutic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Radioactive Therapeutic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Radioactive Therapeutic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Nihon Medi-Physics Company Information, Head Office, and Major Competitors
Table 6. Nihon Medi-Physics Major Business
Table 7. Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Solutions
Table 8. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Nihon Medi-Physics Recent Developments and Future Plans
Table 10. ITM Isotopen Technologien Mьnchen AG Company Information, Head Office, and Major Competitors
Table 11. ITM Isotopen Technologien Mьnchen AG Major Business
Table 12. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Solutions
Table 13. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. ITM Isotopen Technologien Mьnchen AG Recent Developments and Future Plans
Table 15. Advanced Accelerator Applications Company Information, Head Office, and Major Competitors
Table 16. Advanced Accelerator Applications Major Business
Table 17. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Solutions
Table 18. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Advanced Accelerator Applications Recent Developments and Future Plans
Table 20. Telix Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Telix Pharmaceuticals Major Business
Table 22. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
Table 23. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Telix Pharmaceuticals Recent Developments and Future Plans
Table 25. GE Healthcare Company Information, Head Office, and Major Competitors
Table 26. GE Healthcare Major Business
Table 27. GE Healthcare Radioactive Therapeutic Drugs Product and Solutions
Table 28. GE Healthcare Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. GE Healthcare Recent Developments and Future Plans
Table 30. Theragnostics Ltd. Company Information, Head Office, and Major Competitors
Table 31. Theragnostics Ltd. Major Business
Table 32. Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Solutions
Table 33. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Theragnostics Ltd. Recent Developments and Future Plans
Table 35. NuView Life Sciences Company Information, Head Office, and Major Competitors
Table 36. NuView Life Sciences Major Business
Table 37. NuView Life Sciences Radioactive Therapeutic Drugs Product and Solutions
Table 38. NuView Life Sciences Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NuView Life Sciences Recent Developments and Future Plans
Table 40. Jubilant Pharma Limited Company Information, Head Office, and Major Competitors
Table 41. Jubilant Pharma Limited Major Business
Table 42. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Solutions
Table 43. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Jubilant Pharma Limited Recent Developments and Future Plans
Table 45. Lantheus Holdings, Inc. Company Information, Head Office, and Major Competitors
Table 46. Lantheus Holdings, Inc. Major Business
Table 47. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Solutions
Table 48. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lantheus Holdings, Inc. Recent Developments and Future Plans
Table 50. Curium Pharma Company Information, Head Office, and Major Competitors
Table 51. Curium Pharma Major Business
Table 52. Curium Pharma Radioactive Therapeutic Drugs Product and Solutions
Table 53. Curium Pharma Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Curium Pharma Recent Developments and Future Plans
Table 55. Bayer AG Company Information, Head Office, and Major Competitors
Table 56. Bayer AG Major Business
Table 57. Bayer AG Radioactive Therapeutic Drugs Product and Solutions
Table 58. Bayer AG Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer AG Recent Developments and Future Plans
Table 60. Clarity Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Clarity Pharmaceuticals Major Business
Table 62. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
Table 63. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Clarity Pharmaceuticals Recent Developments and Future Plans
Table 65. Global Radioactive Therapeutic Drugs Revenue (USD Million) by Players (2018-2023)
Table 66. Global Radioactive Therapeutic Drugs Revenue Share by Players (2018-2023)
Table 67. Breakdown of Radioactive Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Radioactive Therapeutic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Radioactive Therapeutic Drugs Players
Table 70. Radioactive Therapeutic Drugs Market: Company Product Type Footprint
Table 71. Radioactive Therapeutic Drugs Market: Company Product Application Footprint
Table 72. Radioactive Therapeutic Drugs New Market Entrants and Barriers to Market Entry
Table 73. Radioactive Therapeutic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Radioactive Therapeutic Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Radioactive Therapeutic Drugs Consumption Value Share by Type (2018-2023)
Table 76. Global Radioactive Therapeutic Drugs Consumption Value Forecast by Type (2024-2029)
Table 77. Global Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023)
Table 78. Global Radioactive Therapeutic Drugs Consumption Value Forecast by Application (2024-2029)
Table 79. North America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Radioactive Therapeutic Drugs Raw Material
Table 110. Key Suppliers of Radioactive Therapeutic Drugs Raw Materials
LIST OF FIGURE
s
Figure 1. Radioactive Therapeutic Drugs Picture
Figure 2. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Type in 2022
Figure 4. Oncology
Figure 5. Cardiology
Figure 6. Others
Figure 7. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Radioactive Therapeutic Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Picture
Figure 10. Academic & Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Radioactive Therapeutic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Radioactive Therapeutic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Radioactive Therapeutic Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Radioactive Therapeutic Drugs Revenue Share by Players in 2022
Figure 23. Radioactive Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Radioactive Therapeutic Drugs Market Share in 2022
Figure 25. Global Top 6 Players Radioactive Therapeutic Drugs Market Share in 2022
Figure 26. Global Radioactive Therapeutic Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Radioactive Therapeutic Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Radioactive Therapeutic Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Radioactive Therapeutic Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Radioactive Therapeutic Drugs Market Drivers
Figure 65. Radioactive Therapeutic Drugs Market Restraints
Figure 66. Radioactive Therapeutic Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Radioactive Therapeutic Drugs in 2022
Figure 69. Manufacturing Process Analysis of Radioactive Therapeutic Drugs
Figure 70. Radioactive Therapeutic Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Table 1. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Radioactive Therapeutic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Radioactive Therapeutic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Nihon Medi-Physics Company Information, Head Office, and Major Competitors
Table 6. Nihon Medi-Physics Major Business
Table 7. Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Solutions
Table 8. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Nihon Medi-Physics Recent Developments and Future Plans
Table 10. ITM Isotopen Technologien Mьnchen AG Company Information, Head Office, and Major Competitors
Table 11. ITM Isotopen Technologien Mьnchen AG Major Business
Table 12. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Solutions
Table 13. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. ITM Isotopen Technologien Mьnchen AG Recent Developments and Future Plans
Table 15. Advanced Accelerator Applications Company Information, Head Office, and Major Competitors
Table 16. Advanced Accelerator Applications Major Business
Table 17. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Solutions
Table 18. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Advanced Accelerator Applications Recent Developments and Future Plans
Table 20. Telix Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Telix Pharmaceuticals Major Business
Table 22. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
Table 23. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Telix Pharmaceuticals Recent Developments and Future Plans
Table 25. GE Healthcare Company Information, Head Office, and Major Competitors
Table 26. GE Healthcare Major Business
Table 27. GE Healthcare Radioactive Therapeutic Drugs Product and Solutions
Table 28. GE Healthcare Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. GE Healthcare Recent Developments and Future Plans
Table 30. Theragnostics Ltd. Company Information, Head Office, and Major Competitors
Table 31. Theragnostics Ltd. Major Business
Table 32. Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Solutions
Table 33. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Theragnostics Ltd. Recent Developments and Future Plans
Table 35. NuView Life Sciences Company Information, Head Office, and Major Competitors
Table 36. NuView Life Sciences Major Business
Table 37. NuView Life Sciences Radioactive Therapeutic Drugs Product and Solutions
Table 38. NuView Life Sciences Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NuView Life Sciences Recent Developments and Future Plans
Table 40. Jubilant Pharma Limited Company Information, Head Office, and Major Competitors
Table 41. Jubilant Pharma Limited Major Business
Table 42. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Solutions
Table 43. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Jubilant Pharma Limited Recent Developments and Future Plans
Table 45. Lantheus Holdings, Inc. Company Information, Head Office, and Major Competitors
Table 46. Lantheus Holdings, Inc. Major Business
Table 47. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Solutions
Table 48. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lantheus Holdings, Inc. Recent Developments and Future Plans
Table 50. Curium Pharma Company Information, Head Office, and Major Competitors
Table 51. Curium Pharma Major Business
Table 52. Curium Pharma Radioactive Therapeutic Drugs Product and Solutions
Table 53. Curium Pharma Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Curium Pharma Recent Developments and Future Plans
Table 55. Bayer AG Company Information, Head Office, and Major Competitors
Table 56. Bayer AG Major Business
Table 57. Bayer AG Radioactive Therapeutic Drugs Product and Solutions
Table 58. Bayer AG Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer AG Recent Developments and Future Plans
Table 60. Clarity Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Clarity Pharmaceuticals Major Business
Table 62. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Solutions
Table 63. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Clarity Pharmaceuticals Recent Developments and Future Plans
Table 65. Global Radioactive Therapeutic Drugs Revenue (USD Million) by Players (2018-2023)
Table 66. Global Radioactive Therapeutic Drugs Revenue Share by Players (2018-2023)
Table 67. Breakdown of Radioactive Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Radioactive Therapeutic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Radioactive Therapeutic Drugs Players
Table 70. Radioactive Therapeutic Drugs Market: Company Product Type Footprint
Table 71. Radioactive Therapeutic Drugs Market: Company Product Application Footprint
Table 72. Radioactive Therapeutic Drugs New Market Entrants and Barriers to Market Entry
Table 73. Radioactive Therapeutic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Radioactive Therapeutic Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Radioactive Therapeutic Drugs Consumption Value Share by Type (2018-2023)
Table 76. Global Radioactive Therapeutic Drugs Consumption Value Forecast by Type (2024-2029)
Table 77. Global Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023)
Table 78. Global Radioactive Therapeutic Drugs Consumption Value Forecast by Application (2024-2029)
Table 79. North America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Radioactive Therapeutic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Radioactive Therapeutic Drugs Raw Material
Table 110. Key Suppliers of Radioactive Therapeutic Drugs Raw Materials
LIST OF FIGURE
s
Figure 1. Radioactive Therapeutic Drugs Picture
Figure 2. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Type in 2022
Figure 4. Oncology
Figure 5. Cardiology
Figure 6. Others
Figure 7. Global Radioactive Therapeutic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Radioactive Therapeutic Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Picture
Figure 10. Academic & Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Radioactive Therapeutic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Radioactive Therapeutic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Radioactive Therapeutic Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Radioactive Therapeutic Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Radioactive Therapeutic Drugs Revenue Share by Players in 2022
Figure 23. Radioactive Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Radioactive Therapeutic Drugs Market Share in 2022
Figure 25. Global Top 6 Players Radioactive Therapeutic Drugs Market Share in 2022
Figure 26. Global Radioactive Therapeutic Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Radioactive Therapeutic Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Radioactive Therapeutic Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Radioactive Therapeutic Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Radioactive Therapeutic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Radioactive Therapeutic Drugs Market Drivers
Figure 65. Radioactive Therapeutic Drugs Market Restraints
Figure 66. Radioactive Therapeutic Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Radioactive Therapeutic Drugs in 2022
Figure 69. Manufacturing Process Analysis of Radioactive Therapeutic Drugs
Figure 70. Radioactive Therapeutic Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
